Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Clonal chromosomal abnormalities in CD34 CD38 hematopoietic cells from cytogenetically normal chronic myeloid leukemia patients with a complete cytogenetic response to tyrosine kinase inhibitorsBUMM, T ; DEININGER, J ; NEWELL, A. H ; LAWCE, H ; OLSON, S ; MAURO, M ; DRUKER, B ; DEININGER, MLeukemia, 2010-08, Vol.24 (8), p.1525-1528 [Periódico revisado por pares]Avenel, NJ: Nature Publishing GroupTexto completo disponível |
|
2 |
Material Type: Artigo
|
Ponatinib in Refractory Philadelphia Chromosome–Positive LeukemiasCortes, Jorge E ; Kantarjian, Hagop ; Shah, Neil P ; Bixby, Dale ; Mauro, Michael J ; Flinn, Ian ; O'Hare, Thomas ; Hu, Simin ; Narasimhan, Narayana I ; Rivera, Victor M ; Clackson, Tim ; Turner, Christopher D ; Haluska, Frank G ; Druker, Brian J ; Deininger, Michael W.N ; Talpaz, MosheThe New England journal of medicine, 2012-11, Vol.367 (22), p.2075-2088 [Periódico revisado por pares]Waltham, MA: Massachusetts Medical SocietyTexto completo disponível |
|
3 |
Material Type: Artigo
|
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor FailureHughes, Timothy P ; Mauro, Michael J ; Cortes, Jorge E ; Minami, Hironobu ; Rea, Delphine ; DeAngelo, Daniel J ; Breccia, Massimo ; Goh, Yeow-Tee ; Talpaz, Moshe ; Hochhaus, Andreas ; le Coutre, Philipp ; Ottmann, Oliver ; Heinrich, Michael C ; Steegmann, Juan L ; Deininger, Michael W.N ; Janssen, Jeroen J.W.M ; Mahon, Francois-Xavier ; Minami, Yosuke ; Yeung, David ; Ross, David M ; Tallman, Martin S ; Park, Jae H ; Druker, Brian J ; Hynds, David ; Duan, Yuyan ; Meille, Christophe ; Hourcade-Potelleret, Florence ; Vanasse, K. Gary ; Lang, Fabian ; Kim, Dong-WookThe New England journal of medicine, 2019-12, Vol.381 (24), p.2315-2326 [Periódico revisado por pares]United States: Massachusetts Medical SocietyTexto completo disponível |
|
4 |
Material Type: Artigo
|
In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutantsO'HARE, Thomas ; WALTERS, Denise K ; DRUKER, Brian J ; STOFFREGEN, Eric P ; TAIPING JIA ; MANLEY, Paul W ; MESTAN, Jürgen ; COWAN-JACOB, Sandra W ; LEE, Francis Y ; HEINRICH, Michael C ; DEININGER, Michael W. NCancer research (Chicago, Ill.), 2005-06, Vol.65 (11), p.4500-4505 [Periódico revisado por pares]Philadelphia, PA: American Association for Cancer ResearchTexto completo disponível |
|
5 |
Material Type: Artigo
|
Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE TrialCortes, Jorge E ; Gambacorti-Passerini, Carlo ; Deininger, Michael W ; Mauro, Michael J ; Chuah, Charles ; Kim, Dong-Wook ; Dyagil, Irina ; Glushko, Nataliia ; Milojkovic, Dragana ; le Coutre, Philipp ; Garcia-Gutierrez, Valentin ; Reilly, Laurence ; Jeynes-Ellis, Allison ; Leip, Eric ; Bardy-Bouxin, Nathalie ; Hochhaus, Andreas ; Brümmendorf, Tim HJournal of clinical oncology, 2018-01, Vol.36 (3), p.231-237 [Periódico revisado por pares]United States: American Society of Clinical OncologyTexto completo disponível |
|
6 |
Material Type: Artigo
|
Tyrosine Kinase Inhibitor-Associated Cardiovascular Toxicity in Chronic Myeloid LeukemiaMoslehi, Javid J ; Deininger, MichaelJournal of clinical oncology, 2015-12, Vol.33 (35), p.4210-4218 [Periódico revisado por pares]United States: American Society of Clinical OncologyTexto completo disponível |
|
7 |
Material Type: Artigo
|
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemiaHochhaus, A ; Baccarani, M ; Silver, R T ; Schiffer, C ; Apperley, J F ; Cervantes, F ; Clark, R E ; Cortes, J E ; Deininger, M W ; Guilhot, F ; Hjorth-Hansen, H ; Hughes, T P ; Janssen, J J W M ; Kantarjian, H M ; Kim, D W ; Larson, R A ; Lipton, J H ; Mahon, F X ; Mayer, J ; Nicolini, F ; Niederwieser, D ; Pane, F ; Radich, J P ; Rea, D ; Richter, J ; Rosti, G ; Rousselot, P ; Saglio, G ; Saußele, S ; Soverini, S ; Steegmann, J L ; Turkina, A ; Zaritskey, A ; Hehlmann, RLeukemia, 2020-04, Vol.34 (4), p.966-984 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
|
8 |
Material Type: Artigo
|
Targeting the BCR-ABL Signaling Pathway in Therapy-Resistant Philadelphia Chromosome-Positive LeukemiaO'HARE, Thomas ; DEININGER, Michael W. N ; EIDE, Christopher A ; CLACKSON, Tim ; DRUKER, Brian JClinical cancer research, 2011-01, Vol.17 (2), p.212-221 [Periódico revisado por pares]Philadelphia, PA: American Association for Cancer ResearchTexto completo disponível |
|
9 |
Material Type: Artigo
|
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid LeukemiaHochhaus, Andreas ; Larson, Richard A ; Guilhot, François ; Radich, Jerald P ; Branford, Susan ; Hughes, Timothy P ; Baccarani, Michele ; Deininger, Michael W ; Cervantes, Francisco ; Fujihara, Satoko ; Ortmann, Christine-Elke ; Menssen, Hans D ; Kantarjian, Hagop ; O’Brien, Stephen G ; Druker, Brian JThe New England journal of medicine, 2017-03, Vol.376 (10), p.917-927 [Periódico revisado por pares]United States: Massachusetts Medical SocietyTexto completo disponível |
|
10 |
Material Type: Artigo
|
A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive LeukemiasCortes, J.E ; Kim, D.-W ; Pinilla-Ibarz, J ; le Coutre, P ; Paquette, R ; Chuah, C ; Nicolini, F.E ; Apperley, J.F ; Khoury, H.J ; Talpaz, M ; DiPersio, J ; DeAngelo, D.J ; Abruzzese, E ; Rea, D ; Baccarani, M ; Müller, M.C ; Gambacorti-Passerini, C ; Wong, S ; Lustgarten, S ; Rivera, V.M ; Clackson, T ; Turner, C.D ; Haluska, F.G ; Guilhot, F ; Deininger, M.W ; Hochhaus, A ; Hughes, T ; Goldman, J.M ; Shah, N.P ; Kantarjian, HThe New England journal of medicine, 2013-11, Vol.369 (19), p.1783-1796 [Periódico revisado por pares]Waltham, MA: Massachusetts Medical SocietyTexto completo disponível |